'Diagnostic downshift': clinical and system consequences of extrapolating secondary care testing tactics to primary care
- PMID: 34099498
- DOI: 10.1136/bmjebm-2020-111629
'Diagnostic downshift': clinical and system consequences of extrapolating secondary care testing tactics to primary care
Abstract
Numerous drivers push specialist diagnostic approaches down to primary care ('diagnostic downshift'), intuitively welcomed by clinicians and patients. However, primary care's different population and processes result in under-recognised, unintended consequences. Testing performs poorer in primary care, with indication creep due to earlier, more undifferentiated presentation and reduced accuracy due to spectrum bias and the 'false-positive paradox'. In low-prevalence settings, tests without near-100% specificity have their useful yield eclipsed by greater incidental or false-positive findings. Ensuing cascades and multiplier effects can generate clinician workload, patient anxiety, further low-value tests, referrals, treatments and a potentially nocebic population 'disease' burden of unclear benefit. Increased diagnostics earlier in pathways can burden patients and stretch general practice (GP) workloads, inducing downstream service utilisation and unintended 'market failure' effects. Evidence is tenuous for reducing secondary care referrals, providing patient reassurance or meaningfully improving clinical outcomes. Subsequently, inflated investment in per capita testing, at a lower level in a healthcare system, may deliver diminishing or even negative economic returns. Test cost poorly represents 'value', neglecting under-recognised downstream consequences, which must be balanced against therapeutic yield. With lower positive predictive values, more tests are required per true diagnosis and cost-effectiveness is rarely robust. With fixed secondary care capacity, novel primary care testing is an added cost pressure, rarely reducing hospital activity. GP testing strategies require real-world evaluation, in primary care populations, of all downstream consequences. Test formularies should be scrutinised in view of the setting of care, with interventions to focus rational testing towards those with higher pretest probabilities, while improving interpretation and communication of results.
Keywords: diagnosis; general practice; pathology; primary healthcare; radiology.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Unintended consequences: quantifying the benefits, iatrogenic harms and downstream cascade costs of musculoskeletal MRI in UK primary care.BMJ Open Qual. 2021 Jul;10(3):e001287. doi: 10.1136/bmjoq-2020-001287. BMJ Open Qual. 2021. PMID: 34215659 Free PMC article.
-
Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 May 6;21(2):1-125. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34055110 Free PMC article.
-
Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.Health Technol Assess. 2006 Apr;10(10):1-176. doi: 10.3310/hta10100. Health Technol Assess. 2006. PMID: 16595079
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.Health Technol Assess. 2019 Mar;23(13):1-226. doi: 10.3310/hta23130. Health Technol Assess. 2019. PMID: 30917097 Free PMC article.
Cited by
-
Unintended consequences: quantifying the benefits, iatrogenic harms and downstream cascade costs of musculoskeletal MRI in UK primary care.BMJ Open Qual. 2021 Jul;10(3):e001287. doi: 10.1136/bmjoq-2020-001287. BMJ Open Qual. 2021. PMID: 34215659 Free PMC article.
-
Irish general practitioner (GP) perspectives on impact of direct access radiology on patient care in the community: results from a mixed-methods study.Ir J Med Sci. 2024 Feb;193(1):425-434. doi: 10.1007/s11845-023-03419-1. Epub 2023 Jun 24. Ir J Med Sci. 2024. PMID: 37354242 Free PMC article.
-
Artificial intelligence for diagnosing exudative age-related macular degeneration.Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2. Cochrane Database Syst Rev. 2024. PMID: 39417312
MeSH terms
LinkOut - more resources
Full Text Sources